These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30242498)

  • 21. Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation/intrauterine insemination a good option?
    Souter I; Dimitriadis I; Baltagi LM; Meeker JD; Petrozza JC
    Am J Obstet Gynecol; 2014 Jul; 211(1):62.e1-8. PubMed ID: 24487006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicle stimulating hormone or clomiphene citrate in intrauterine insemination with ovarian stimulation for unexplained subfertility: a role for treatment selection markers?
    Danhof NA; van Eekelen R; Repping S; Mol BWJ; van der Veen F; van Wely M; Mochtar MH;
    Reprod Biomed Online; 2019 Jun; 38(6):938-942. PubMed ID: 30981620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Number of Intermediate Follicles. An Independent Risk Factor of Multiple Pregnancies in Intrauterine Insemination Cycles with Recombinant Follicle-Stimulating Hormone.
    Scalici E; Bechoua S; Jimenez C; Astruc K; Sagot P; Hamamah S
    J Reprod Med; 2015; 60(7-8):279-86. PubMed ID: 26380485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-Müllerian hormone levels.
    Vagios S; Sacha CR; Hammer KC; Dimitriadis I; James KE; Bormann CL; Souter I
    J Assist Reprod Genet; 2021 Jul; 38(7):1827-1833. PubMed ID: 33934267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
    Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
    Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of in vitro fertilization versus intrauterine insemination in patients with low anti-Müllerian hormone levels. A single-center retrospective study of 639 + 119 cycles.
    Sapet C; Gavoille A; Sesques A; Freour T; Subtil F; Salle B
    J Gynecol Obstet Hum Reprod; 2021 Mar; 50(3):101874. PubMed ID: 32687891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH.
    Chan C; Liu K
    J Assist Reprod Genet; 2014 Oct; 31(10):1317-21. PubMed ID: 25113621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Value of Anti-Müllerian Hormone in Predicting Clinical Pregnancy After Intrauterine Insemination.
    Dondik Y; Virji N; Butler TS; Gaskins JT; Pagidas K; Sung L
    J Obstet Gynaecol Can; 2017 Oct; 39(10):880-885. PubMed ID: 28647445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of infertility duration and follicle size according to pregnancy success in women undergoing ovulation induction with gonadotropins and intrauterine insemination.
    Kuru Pekcan M; Tokmak A; Ulubasoglu H; Kement M; Özakşit G
    J Obstet Gynaecol; 2023 Dec; 43(1):2173058. PubMed ID: 36920100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles.
    Balasch J; Ballescá JL; Pimentel C; Creus M; Fábregues F; Vanrell JA
    Hum Reprod; 1994 Oct; 9(10):1863-6. PubMed ID: 7844217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can anti-Müllerian hormone predict success outcomes in donor sperm inseminations?
    González-Foruria I; Martínez F; Rodríguez-Purata J; Ballester M; Alonso-Mosquera V; Buxaderas R; Rodríguez I; Coroleu B
    Gynecol Endocrinol; 2019 Jan; 35(1):40-43. PubMed ID: 30324829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
    Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
    Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
    Ragni G; Caliari I; Nicolosi AE; Arnoldi M; Somigliana E; Crosignani PG
    Fertil Steril; 2006 Mar; 85(3):619-24. PubMed ID: 16500328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of ovarian response in intrauterine insemination patients and development of a dosage nomogram.
    Freiesleben NL; Lossl K; Bogstad J; Bredkjaer HE; Toft B; Loft A; Bangsboll S; Pinborg A; Budtz-Jørgensen E; Andersen AN
    Reprod Biomed Online; 2008 Nov; 17(5):632-41. PubMed ID: 18983747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.